Atlas Trials

CABOTEGRAVIR/LENACAPAVIR DUAL LONG ACTING THERAPY (COHORT IMEA 074)

Clinical trial NCT07402044 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07402044
Sponsor
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
CABOTEGRAVIRLENACAPAVIR
Start date
2026-03-15
Primary completion
2028-03-15
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.